A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Clinical trial NCT06709014 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06709014
Sponsor: Annovis Bio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Early Alzheimers Disease

Start date: 2025-02-04
Primary completion: 2027-12-01
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.